SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1159.1026.95 (+2.38 %)
PREV CLOSE ( ) 1132.15
OPEN PRICE ( ) 1148.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 106658
TODAY'S LOW / HIGH ( )1135.50 1167.00
52 WK LOW / HIGH ( )922.45 1169.9
NSE1158.6526.35 (+2.33 %)
PREV CLOSE( ) 1132.30
OPEN PRICE ( ) 1134.30
BID PRICE (QTY) 1158.65 (24)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2288577
TODAY'S LOW / HIGH( ) 1134.30 1167.40
52 WK LOW / HIGH ( )922.45 1169.7
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
- Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
29Sep Sun Pharma’s arm to acquire balance 25
Sun Pharmaceutical Industries’ wholly-owned Subsidiary -- Sun Pharma (Ne..
29Sep Sun Pharma shines as its arm to acquir
Sun Pharmaceutical Industries is currently trading at Rs. 1162.70, up by..
27Sep Sun Pharma’s arm launches WINLEVI in C
Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Can..
27Sep Sun Pharma climbs after its arm launch
Sun Pharmaceutical Industries is currently trading at Rs. 1139.35, up by..
25Sep Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that it enclosed the details..
Financials
Rs. in Millions
QTR Jun 23 ANNUAL 23
Net Profit3806.416907.2
Gross Profit 3898.8 17410.5
Operating Profit 1112367518.9
Net Sales 44660.7208121.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 23159.10 (3.44%)
M.Cap (Rs. in Cr)49211.47
Dr. Reddy's Lab (BSE)
 5586.75 (2.97%)
M.Cap (Rs. in Cr)93178.48
Sanofi India (BSE)
 7206.50 (2.09%)
M.Cap (Rs. in Cr)16597.02
Divi's Lab (BSE)
 3764.75 (2.75%)
M.Cap (Rs. in Cr)99942.28
Alkem Laboratories (BSE)
 3607.65 (2.41%)
M.Cap (Rs. in Cr)43134.87
Shareholding Pattern
PROMOTERS 54.48%
MUTUAL FUNDS/UTI 13.16%
NON-INSTITUTION 9.29%
FI/BANKS/INSURANCE 5.27%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.